148 related articles for article (PubMed ID: 37655276)
1. Assessing MTT and sulforhodamine B cell proliferation assays under multiple oxygen environments.
Yao M; Walker G; Gamcsik MP
Cytotechnology; 2023 Oct; 75(5):381-390. PubMed ID: 37655276
[TBL] [Abstract][Full Text] [Related]
2. Mixing and delivery of multiple controlled oxygen environments to a single multiwell culture plate.
Yao M; Sattler T; Rabbani ZN; Pulliam T; Walker G; Gamcsik MP
Am J Physiol Cell Physiol; 2018 Nov; 315(5):C766-C775. PubMed ID: 30183322
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Sertoli Cell Proliferation by 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide and Sulforhodamine B Assays.
Martins AD; Oliveira PF; Alves MG
Curr Protoc Toxicol; 2019 Sep; 81(1):e85. PubMed ID: 31529795
[TBL] [Abstract][Full Text] [Related]
4. Limitations of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay when compared to three commonly used cell enumeration assays.
van Tonder A; Joubert AM; Cromarty AD
BMC Res Notes; 2015 Feb; 8():47. PubMed ID: 25884200
[TBL] [Abstract][Full Text] [Related]
5. Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines.
Rubinstein LV; Shoemaker RH; Paull KD; Simon RM; Tosini S; Skehan P; Scudiero DA; Monks A; Boyd MR
J Natl Cancer Inst; 1990 Jul; 82(13):1113-8. PubMed ID: 2359137
[TBL] [Abstract][Full Text] [Related]
6. Comparing automated cell imaging with conventional methods of measuring cell proliferation and viability.
Featherston T; Helem S; Smyth LCD; Hampton MB; Paumann-Page M
Toxicol Mech Methods; 2024 Jun; ():1-11. PubMed ID: 38887791
[TBL] [Abstract][Full Text] [Related]
7. Amino Alcohol Acrylonitriles as Activators of the Aryl Hydrocarbon Receptor Pathway: An Unexpected MTT Phenotypic Screening Outcome.
Baker JR; Russell CC; Gilbert J; Sakoff JA; McCluskey A
ChemMedChem; 2020 Mar; 15(6):490-505. PubMed ID: 32012442
[TBL] [Abstract][Full Text] [Related]
8. Differences in estimates of cisplatin-induced cell kill in vitro between colorimetric and cell count/colony assays.
Henriksson E; Kjellén E; Wahlberg P; Wennerberg J; Kjellström JH
In Vitro Cell Dev Biol Anim; 2006; 42(10):320-3. PubMed ID: 17316066
[TBL] [Abstract][Full Text] [Related]
9. Assay of anticancer drugs in tissue culture: comparison of a tetrazolium-based assay and a protein binding dye assay in short-term cultures derived from human malignant glioma.
Haselsberger K; Peterson DC; Thomas DG; Darling JL
Anticancer Drugs; 1996 May; 7(3):331-8. PubMed ID: 8792008
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of viability assays for anthocyanins in cultured cells.
Elisia I; Popovich DG; Hu C; Kitts DD
Phytochem Anal; 2008; 19(6):479-86. PubMed ID: 18435529
[TBL] [Abstract][Full Text] [Related]
11. Sulforhodamine B assay and chemosensitivity.
Voigt W
Methods Mol Med; 2005; 110():39-48. PubMed ID: 15901925
[TBL] [Abstract][Full Text] [Related]
12. A comparison of clonogenic, microtetrazolium and sulforhodamine B assays for determination of cisplatin cytotoxicity in human ovarian carcinoma cell lines.
Perez RP; Godwin AK; Handel LM; Hamilton TC
Eur J Cancer; 1993; 29A(3):395-9. PubMed ID: 8398340
[TBL] [Abstract][Full Text] [Related]
13. Avoiding the Interference of Doxorubicin with MTT Measurements on the MCF-7 Breast Cancer Cell Line.
Luis C; Castaño-Guerrero Y; Soares R; Sales G; Fernandes R
Methods Protoc; 2019 Apr; 2(2):. PubMed ID: 31164609
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the Phenolic Compound, Gallic Acid from
Maheshwari R; Shreedhara CS; Polu PR; Managuli RS; Xavier SK; Lobo R; Setty M; Mutalik S
Pharmacogn Mag; 2017 Oct; 13(Suppl 3):S693-S699. PubMed ID: 29142435
[TBL] [Abstract][Full Text] [Related]
15. Unraveling the mechanisms behind the enhanced MTT conversion by irradiated breast cancer cells.
Blockhuys S; Vanhoecke B; Smet J; De Paepe B; Van Coster R; Bracke M; De Wagter C
Radiat Res; 2013 Apr; 179(4):433-43. PubMed ID: 23465060
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing.
Keepers YP; Pizao PE; Peters GJ; van Ark-Otte J; Winograd B; Pinedo HM
Eur J Cancer; 1991; 27(7):897-900. PubMed ID: 1834124
[TBL] [Abstract][Full Text] [Related]
17. The mitochondrial uncoupler dicumarol disrupts the MTT assay.
Collier AC; Pritsos CA
Biochem Pharmacol; 2003 Jul; 66(2):281-7. PubMed ID: 12826270
[TBL] [Abstract][Full Text] [Related]
18. Cell Enumeration Assays: Application of the MTT and Sulforhodamine B Assays to Lipopolysaccharide-Stimulated Neonatal Rodent Microglia.
Facci L; Skaper SD
Methods Mol Biol; 2018; 1727():167-178. PubMed ID: 29222781
[TBL] [Abstract][Full Text] [Related]
19. Lutein inhibits proliferation, invasion and migration of hypoxic breast cancer cells via downregulation of HES1.
Li Y; Zhang Y; Liu X; Wang M; Wang P; Yang J; Zhang S
Int J Oncol; 2018 Jun; 52(6):2119-2129. PubMed ID: 29620169
[TBL] [Abstract][Full Text] [Related]
20. Flow-Encoded Oxygen Control to Track the Time-Dependence of Molecular Changes Induced by Static or Cycling Hypoxia.
Yao M; Rabbani ZN; Sattler T; Nguyen KG; Zaharoff DA; Walker G; Gamcsik MP
Anal Chem; 2019 Dec; 91(23):15032-15039. PubMed ID: 31694368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
